Recruiting PHASE1 INTERVENTIONAL 1-arm
NCT07118176
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
PET Imaging Study of 68Ga-FAPI-46 Biodistribution in Cancer Patients
Sponsor: Jonsson Comprehensive Cancer Center
Conditions
Anal Carcinoma Bladder Carcinoma Breast Carcinoma Cervical Carcinoma Cholangiocarcinoma Colorectal Carcinoma Esophageal Carcinoma Gastric Carcinoma Head and Neck Carcinoma Hematopoietic and Lymphatic System Neoplasm Hepatocellular Carcinoma Lung Carcinoma Malignant Adrenal Gland Neoplasm Malignant Brain Neoplasm Malignant Neoplasm of Unknown Primary Malignant Solid Neoplasm Malignant Testicular Neoplasm Malignant Uterine Neoplasm Neuroendocrine Neoplasm Ovarian Carcinoma Pancreatic Carcinoma Penile Carcinoma Pleural Carcinomatosis Primary Peritoneal Carcinoma Prostate Carcinoma Salivary Gland Carcinoma Sarcoma Skin Carcinoma Solitary Fibrous Tumor Thymus Carcinoma Thyroid Gland Carcinoma Thyroid Gland Medullary Carcinoma Urothelial Carcinoma Vaginal Carcinoma
Interventions
Computed Tomography Fludeoxyglucose F-18 Gallium Ga 68 FAPi-46 Positron Emission Tomography
Updated 1 time since 2025 Last updated: Aug 5, 2025 Started: Aug 1, 2025 Primary completion: Sep 6, 2026 Completion: Sep 7, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Anal Carcinoma and Bladder Carcinoma, this trial is actively recruiting participants. The trial is conducted by Jonsson Comprehensive Cancer Center and has accumulated 1 data snapshot since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Jonsson Comprehensive Cancer Center
Data source: Jonsson Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .